REEMA NAMAN

Podiatric Medicine & Surgery Service Providers|Podiatrist|Foot & Ankle Surgery FLINT, MI NPI 1124649892

General Payments — all program years on this page

$7,964.02

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 95
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,172.98 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,172.9817

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Stryker Corporation $205.833
Integra LifeSciences Corporation $202.094
ABBVIE INC. $155.342
DePuy Synthes Sales Inc. $144.322
Zak Ortho $139.481
Kerecis Limited $132.041
Amgen Inc. $110.761
TREACE MEDICAL CONCEPTS, INC. $63.052
Novo Nordisk AS $20.071

By program year

Program yearAmountRecords
2021 $297.7314
2022 $3,062.0222
2023 $3,431.2942
2024 $1,172.9817

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1077856036 DePuy Synthes Sales Inc. $106.76 04/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077856093 DePuy Synthes Sales Inc. $37.56 04/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092527897 Zak Ortho $139.48 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097110685 Novo Nordisk Inc $20.07 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105097507 ABBVIE INC. $30.35 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105097509 ABBVIE INC. $124.99 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115959083 Amgen Inc. $110.76 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119926429 Stryker Corporation $8.50 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119926431 Stryker Corporation $45.31 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119926433 Stryker Corporation $152.02 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120116154 Kerecis Limited $132.04 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140127584 Integra LifeSciences Corporation $6.88 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140127588 Integra LifeSciences Corporation $105.84 06/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140127592 Integra LifeSciences Corporation $62.50 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140127597 Integra LifeSciences Corporation $26.87 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151428685 TREACE MEDICAL CONCEPTS, INC. $20.27 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151445351 TREACE MEDICAL CONCEPTS, INC. $42.78 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.